{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:03:15Z","timestamp":1790337795659,"version":"4.1.0"},"reference-count":20,"publisher":"Walter de Gruyter GmbH","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gestational diabetes mellitus (GDM) is a common metabolic complication of pregnancy and is increasingly recognized as a marker of long-term metabolic vulnerability. Beyond its established association with cardiometabolic diseases, emerging epidemiological evidence suggests a potential link between GDM and increased cancer risk, particularly hormone-sensitive malignancies such as endometrial and breast cancer. This narrative review integrates epidemiological and mechanistic evidence exploring the relationship between GDM and long-term oncological susceptibility. Hyperglycemia, hyperinsulinemia, and chronic low-grade inflammation associated with GDM may contribute to proliferative signaling and metabolic dysregulation. Among the proposed mechanisms, insulin\/IGF-1 signaling represents one of the most biologically plausible links, whereas pathways involving PI3K\/Akt\/mTOR activation, metabolic reprogramming, and tumor microenvironment alterations remain largely inferred from broader oncological literature. In addition, persistent metabolic stress during pregnancy may induce long-term epigenetic and immunometabolic changes potentially associated with carcinogenic susceptibility. Although current evidence does not establish a direct causal relationship between GDM and cancer, the integration of epidemiological and mechanistic findings supports the hypothesis that GDM may function as an early marker of systemic metabolic vulnerability associated with increased long-term oncological risk. Further longitudinal and mechanistic studies are needed to clarify this relationship and its clinical implications.<\/jats:p>","DOI":"10.1515\/jbcpp-2026-0136","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:57:59Z","timestamp":1782467879000},"page":"381-386","source":"Crossref","is-referenced-by-count":0,"title":["Gestational diabetes mellitus and long-term cancer risk: a narrative review of epidemiological and mechanistic evidence"],"prefix":"10.1515","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1031-0418","authenticated-orcid":false,"given":"Ana L\u00facia","family":"Abdo Ladeira","sequence":"first","affiliation":[{"name":"Department of Physiological Sciences , Federal University of S\u00e3o Carlos, (UFSCar) , S\u00e3o Carlos , SP , Brazil"},{"name":"Department of Orthopedics and Traumatology , Ribeir\u00e3o Preto Medical School, (FMRP-USP), University of S\u00e3o Paulo , Ribeir\u00e3o Preto , SP , Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_011","doi-asserted-by":"crossref","unstructured":"Wang, Y, Yan, P, Fu, T, Yuan, J, Yang, G, Liu, Y, et al.. Association between gestational diabetes mellitus and cancer in women: a systematic review and meta-analysis of observational studies. Diabetes Metab 2020;46:461\u201371. https:\/\/doi.org\/10.1016\/j.diabet.2020.02.003.","DOI":"10.1016\/j.diabet.2020.02.003"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_012","doi-asserted-by":"crossref","unstructured":"Powe, CE, Tobias, DK, Michels, KB, Chen, WY, Eliassen, AH, Manson, JE, et al.. History of gestational diabetes mellitus and risk of incident invasive breast cancer among parous women in the nurses\u2019 health study II. Cancer Epidemiol Biomarkers Prev 2017;26:321\u20137. https:\/\/doi.org\/10.1158\/1055-9965.EPI-16-0601.","DOI":"10.1158\/1055-9965.EPI-16-0601"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_013","doi-asserted-by":"crossref","unstructured":"Suh, S, Kim, KW. Diabetes and cancer: cancer should be screened in routine diabetes assessment. Diabetes Metab J 2019;43:733\u201343. https:\/\/doi.org\/10.4093\/dmj.2019.0172.","DOI":"10.4093\/dmj.2019.0177"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_020","doi-asserted-by":"crossref","unstructured":"Tian, L, Wen, Y, Liu, C, Li, T, He, F. Association between gestational diabetes mellitus and risk of cancer overall and by specific sites: a systematic review and meta-analysis. Life 2025;15:808. https:\/\/doi.org\/10.3390\/life15050808.","DOI":"10.3390\/life15050808"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_003","doi-asserted-by":"crossref","unstructured":"Hua, H, Kong, Q, Yin, J, Zhang, J, Jiang, Y. Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy. J\u00a0Hematol Oncol 2020;13:64. https:\/\/doi.org\/10.1186\/s13045-020-00904-3.","DOI":"10.1186\/s13045-020-00904-3"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_004","doi-asserted-by":"crossref","unstructured":"Samani, AA, Yakar, S, LeRoith, D, Brodt, P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 2007;28:20\u201347. https:\/\/doi.org\/10.1210\/er.2006-0001.","DOI":"10.1210\/er.2006-0001"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_009","doi-asserted-by":"crossref","unstructured":"Habib, SL, Rojna, M. Diabetes and risk of cancer. ISRN Oncol 2013;2013:583786. https:\/\/doi.org\/10.1155\/2013\/583786.","DOI":"10.1155\/2013\/583786"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_005","doi-asserted-by":"crossref","unstructured":"Koppenol, WH, Bounds, PL, Dang, CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011;11:325\u201337. https:\/\/doi.org\/10.1038\/nrc3038.","DOI":"10.1038\/nrc3038"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_014","doi-asserted-by":"crossref","unstructured":"Cairns, RA, Harris, IS, Mak, TW. Regulation of cancer cell metabolism. Nat Rev Cancer 2011;11:85\u201395. https:\/\/doi.org\/10.1038\/nrc2981.","DOI":"10.1038\/nrc2981"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_010","doi-asserted-by":"crossref","unstructured":"Kenny, PA, Lee, GY, Bissell, MJ. Targeting the tumor microenvironment. Front Biosci 2007;12:3468\u201374. https:\/\/doi.org\/10.2741\/2327.","DOI":"10.2741\/2327"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_017","doi-asserted-by":"crossref","unstructured":"Lunt, SY, Vander Heiden, MG. Aerobic glycolysis. Annu Rev Cell Dev Biol 2011;27:441\u201364. https:\/\/doi.org\/10.1146\/annurev-cellbio-092910-154237.","DOI":"10.1146\/annurev-cellbio-092910-154237"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_015","doi-asserted-by":"crossref","unstructured":"Swietach, P, Vaughan-Jones, RD, Harris, AL. Regulation of tumor pH\u00a0and the role of carbonic anhydrase 9. Cancer Metastasis Rev 2007;26:299\u2013310. https:\/\/doi.org\/10.1007\/s10555-007-9064-0.","DOI":"10.1007\/s10555-007-9064-0"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_016","doi-asserted-by":"crossref","unstructured":"Gillies, RJ, Verduzco, D, Gatenby, RA. Evolutionary dynamics of carcinogenesis. Nat Rev Cancer 2012;12:487\u201393. https:\/\/doi.org\/10.1038\/nrc3298.","DOI":"10.1038\/nrc3298"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_001","doi-asserted-by":"crossref","unstructured":"Hanahan, D, Weinberg, RA. Hallmarks of cancer: the next generation. Cell 2011;144:646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_019","doi-asserted-by":"crossref","unstructured":"Noto, H, Tsujimoto, T, Sasazuki, T, Noda, M. Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Endocr Pract 2011;17:616\u201328. https:\/\/doi.org\/10.4158\/EP10357.RA.","DOI":"10.4158\/EP10357.RA"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_002","doi-asserted-by":"crossref","unstructured":"Dimitrakakis, C, Bofos, I, Karayiannakis, AJ, Zografos, GC. Insulin resistance in endometrial cancer. Gynecol Oncol 2012;117:373\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2012.03.032.","DOI":"10.1016\/j.ygyno.2012.03.032"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_008","doi-asserted-by":"crossref","unstructured":"Vrachnis, N, Iavazzo, C, Iliodromiti, Z, Sifakis, S, Alexandrou, A, Siristatidis, C, et al.. Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives. Arch Gynecol Obstet 2016;293:239\u201346. https:\/\/doi.org\/10.1007\/s00404-015-3858-z.","DOI":"10.1007\/s00404-015-3858-z"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_018","doi-asserted-by":"crossref","unstructured":"Tsilidis, KK, Kasimis, JC, Lopez, DS, Ntzani, EE, Ioannidis, JPA. Type 2 diabetes and cancer: umbrella review of meta-analyses. BMJ 2015;350:g7607. https:\/\/doi.org\/10.1136\/bmj.g7607.","DOI":"10.1136\/bmj.g7607"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_006","doi-asserted-by":"crossref","unstructured":"Evans, JMM, Donnelly, LA, Emslie-Smith, AM, Alessi, DR, Morris, AD. Metformin and reduced risk of cancer in diabetic patients. BMJ 2005;330:1304. https:\/\/doi.org\/10.1136\/bmj.38415.708634.F7.","DOI":"10.1136\/bmj.38415.708634.F7"},{"key":"2026092511254261508_j_jbcpp-2026-0136_ref_007","doi-asserted-by":"crossref","unstructured":"Decensi, A, Puntoni, M, Goodwin, P, Cazzaniga, M, Gennari, A, Bonanni, B, et al..Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res 2010;3:1451\u201361. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-10-0157.","DOI":"10.1158\/1940-6207.CAPR-10-0157"}],"container-title":["Journal of Basic and Clinical Physiology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2026-0136\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2026-0136\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:25:56Z","timestamp":1790335556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2026-0136\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,6,29]]},"published-print":{"date-parts":[[2026,9,25]]}},"alternative-id":["10.1515\/jbcpp-2026-0136"],"URL":"https:\/\/doi.org\/10.1515\/jbcpp-2026-0136","relation":{},"ISSN":["0792-6855","2191-0286"],"issn-type":[{"value":"0792-6855","type":"print"},{"value":"2191-0286","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}